We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+36.73%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$171M
AUM Growth
+$33.6M
Cap. Flow
-$1.93M
Cap. Flow %
-1.13%
Top 10 Hldgs %
91.64%
Holding
48
New
3
Increased
6
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
CFRX
ContraFect Corporation
CFRX
+$613K
2
SITO
SITO MOBILE, LTD
SITO
+$534K
3
ALDR
Alder Biopharmaceuticals
ALDR
+$305K
4
OPK icon
Opko Health
OPK
+$201K
5
VCYT icon
Veracyte
VCYT
+$195K

Top Sells

Rank Stock Value
1
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$2.1M
2
MDVN
MEDIVATION, INC.
MDVN
+$1.13M
3
RLYP
RELYPSA INC COM
RLYP
+$333K
4
CELG
Celgene Corp
CELG
+$216K
5
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$215K

Sector Composition

Rank Sector Weight
1 Healthcare 95.47%
2 Energy 3.24%
3 Consumer Staples 0.54%
4 Industrials 0.36%
5 Consumer Discretionary 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$81.2M 47.4%
777,051
-2,000
-0.3% -$216K
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$59.3M 34.62%
217,580
– –
VRML
3
DELISTED
Vermillion, Inc.
VRML
$3.53M 2.06%
2,717,514
– –
EQT icon
4
EQT Corp
EQT
$31B
$3.07M 1.79%
77,705
– –
BIOL
5
DELISTED
Biolase, Inc.
BIOL
$2.25M 1.31%
103
– –
MASI
6
DELISTED
Masimo
MASI
$2.18M 1.27%
36,600
– –
CFRX
7
DELISTED
ContraFect Corporation
CFRX
$1.8M 1.05%
906
+312
+53% +$613K
OVV icon
8
Ovintiv
OVV
$16.2B
$1.39M 0.81%
26,460
– –
NBIX icon
9
Neurocrine Biosciences
NBIX
$17.2B
$1.28M 0.74%
25,200
– –
TSRO
10
DELISTED
TESARO, Inc.
TSRO
$997K 0.58%
9,950
+1,500
+18% +$140K
MRK icon
11
Merck
MRK
$315B
$936K 0.55%
15,720
– –
YTEN
12
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$917K 0.54%
236
– –
QDEL icon
13
QuidelOrtho
QDEL
$1.19B
$861K 0.5%
38,975
– –
OXFD
14
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$845K 0.49%
67,303
+11,000
+20% +$110K
OMED
15
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$808K 0.47%
70,689
– –
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
$736K 0.43%
30,000
– –
NXTM
17
DELISTED
NxStage Medical Inc.
NXTM
$705K 0.41%
28,200
– –
SITO
18
DELISTED
SITO MOBILE, LTD
SITO
$616K 0.36%
140,000
+120,000
+600% +$534K
ARAY icon
19
Accuray
ARAY
$30.8M
$607K 0.35%
95,300
– –
SIEN
20
DELISTED
Sientra, Inc.
SIEN
$569K 0.33%
6,330
– –
PXD
21
DELISTED
Pioneer Natural Resource Co.
PXD
$557K 0.33%
3,000
– –
CTRA
22
DELISTED
Coterra Energy
CTRA
$542K 0.32%
21,000
– –
CORT icon
23
Corcept Therapeutics
CORT
$9.72B
$520K 0.3%
80,000
– –
ALDR
24
DELISTED
Alder Biopharmaceuticals
ALDR
$496K 0.29%
15,150
+10,000
+194% +$305K
QTNT
25
DELISTED
Quotient Limited Ordinary Shares
QTNT
$455K 0.27%
1,455
– –
1
2

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Birchview Capital held 48 positions worth $171M, up 24% from $138M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Birchview Capital's Q3 2016 filing shows 3 new, 6 increased, 2 reduced and 5 closed positions. Its largest new stake was Opko Health: 20,202 shares worth $214K. The largest sale was HANSEN MEDICAL, INC. COM NEW, an estimated $2.1M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q3 2016 buy was Opko Health: 20,202 shares worth $214K.
  • Birchview Capital added most to ContraFect Corporation in Q3 2016, an estimated $613K increase.
  • Birchview Capital's biggest Q3 2016 reduction was Celgene Corp, cutting an estimated $216K.
  • Birchview Capital fully exited HANSEN MEDICAL, INC. COM NEW in Q3 2016, selling an estimated $2.1M.
  • Birchview Capital's ten largest holdings make up 92% of its $171M portfolio in Q3 2016.
  • Birchview Capital opened 3 new positions and closed 5 in Q3 2016.
  • Birchview Capital's portfolio value rose 24% quarter-over-quarter to $171M.

Based on Birchview Capital's 13F filing for Q3 2016, filed 14 Nov 2016.